Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Katherine Atkins

BSc MRes PhD

Associate Professor
of Infectious Disease Modelling

Room
104

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

Jump to: Affiliations Teaching Research Publications

2013-2014 Associate Research Scientist, Yale University (School of Public Health)

2010-2013 Postdoctoral Associate, Yale University (School of Public Health)

2006-2010 PhD, University of Edinburgh (Biology)

2005-2006 MRes, University of York (Mathematical Biology)

2000-2004 BSc, University of Edinburgh (Mathematics)

Affiliations

Faculty of Epidemiology and Population Health
Department of Infectious Disease Epidemiology

Centres

Centre for the Mathematical Modelling of Infectious Diseases (CMMID)
Vaccine Centre

Teaching

Introduction to Infectious Disease Modelling (MSc)
Introduction to Infectious Disease Modelling (Short Course) 

Research

Research Area
Economic evaluation
Health policy
Infectious disease policy
Public health
Trypanosomes
Vaccines
Disease control
Immunisation
Vector control
Modelling
Discipline
Epidemiology
Mathematical modelling
Disease and Health Conditions
HIV/AIDS
Infectious disease
Influenza
Neglected Tropical Diseases (NTDs)
Vector borne disease
Region
Europe & Central Asia (all income levels)
Sub-Saharan Africa (all income levels)

Selected Publications

Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.
Clark A; Jit M; Warren-Gash C; Guthrie B; Wang HHX; Mercer SW; Sanderson C; McKee M; Troeger C; Ong KL
2020
The Lancet. Global Health
Quantifying the economic cost of antibiotic resistance and the impact of related interventions: rapid methodological review, conceptual framework and recommendations for future studies.
Jit M; Ng DHL; Luangasanatip N; Sandmann F; Atkins KE; Robotham JV; Pouwels KB
2020
BMC MEDICINE
Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study.
Kucharski AJ; Klepac P; Conlan AJK; Kissler SM; Tang ML; Fry H; Gog JR; Edmunds WJ; CMMID COVID-19 working group
2020
The Lancet. Infectious diseases
Number of HIV-1 founder variants is determined by the recency of the source partner infection.
Villabona-Arenas CJ; Hall M; Lythgoe KA; Gaffney SG; Regoes RR; Hué S; Atkins KE
2020
Science (New York, N.Y.)
Cost-effectiveness of introducing national seasonal influenza vaccination for adults aged 60 years and above in mainland China: a modelling analysis.
Yang J; Atkins KE; Feng L; Baguelin M; Wu P; Yan H; Lau EHY; Wu JT; Liu Y; Cowling BJ
2020
BMC medicine
Mathematical modelling for antibiotic resistance control policy: do we know enough?
Knight GM; Davies NG; Colijn C; Coll F; Donker T; Gifford DR; Glover RE; Jit M; Klemm E; Lehtinen S
2019
BMC infectious diseases
The impact of vector migration on the effectiveness of strategies to control gambiense human African trypanosomiasis.
Ndeffo-Mbah ML; Pandey A; Atkins KE; Aksoy S; Galvani AP
2019
PLoS neglected tropical diseases
HIV-1 founder variant multiplicity is determined by the infection stage of the source partner
Villabona-Arenas CJ; Hall M; Lythgoe K; Gaffney S; Regoes R; Hué S; Atkins K
2019
See more Publications

Contact

Room
104

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom